Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Organon & Co.
(NY:
OGN
)
21.80
+0.28 (+1.30%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Organon & Co.
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Lows On Wednesday
August 31, 2022
On Wednesday, 238 companies achieved new lows for the year.
Via
Benzinga
This Women Health Stock Gets Analyst Downgrade On 'Approvability Issues, Restructuring'
August 30, 2022
Via
Benzinga
Organon Expects Lower EBITDA Margin For FY22, Clocks Mixed Q2 Earnings
August 04, 2022
Via
Benzinga
Amphastar's Generic Ganirelix Acetate Injection Scores FDA Approval
April 08, 2022
Via
Benzinga
Merck Spinoff Organon Beats Quarterly Views, But Offers Dim Guidance
February 17, 2022
Organon's sales and earnings fell less than expected, but 2022 sales guidance missed.
Via
Investor's Business Daily
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
August 15, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Via
Benzinga
Organon: Q2 Earnings Insights
August 04, 2022
Organon (NYSE:OGN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon reported in-line EPS of $1.25...
Via
Benzinga
Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange
June 18, 2022
Joincare Pharmaceutical of Shenzhen plans to list on the SIX Swiss stock exchange, an unusual venue for a China biopharma. The company said it aims to broaden its financing sources and increase global...
Via
Talk Markets
Market Selloff
May 10, 2022
In a U.S. market selloff, the strong performance of mostly foreign issues was impressive.
Via
Talk Markets
Organon Easily Beats First-Quarter Expectations Despite Nexplanon Slip-Up
May 05, 2022
The firm's biggest product sustained a hit due to exchange rates and buying patterns.
Via
Investor's Business Daily
Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment
March 31, 2022
Organon & Co (NYSE: OGN)
Via
Benzinga
Healthy Pharma Favorites
March 25, 2022
Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor.
Via
Talk Markets
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
March 09, 2022
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 21, 2022
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
World Markets News For Thursday
February 17, 2022
Ericsson stock lost another 5.27% today in US markets.
Via
Talk Markets
Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B
February 17, 2022
Organon & Co's (NYSE: OGN) Q4 FY21 sales decreased 1% to $1.6 billion, beating the consensus of $1.57 billion. Women's Health increased 6%, driven primarily...
Via
Benzinga
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Warren Buffett Is Selling These Stocks
November 30, 2021
Looking to make money moves like Warren Buffett? Want to know which stocks Buffett is selling? Interested in finding out why these stock sales might be a huge mistake?
Via
Talk Markets
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
Spin-off stocks can be lucrative for shareholders in both legacy businesses and recently created public companies. Here are three to know.
Via
InvestorPlace
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3
November 18, 2021
Warren Buffett's Berkshire Hathaway Inc (NYSE: BRK-A) cleared its stake in Merck & Co Inc (NYSE: MRK) in Q3, right on the eve of a significant stock...
Via
Benzinga
Warren Buffet Takes A Stake In Royalty Pharma And Exits Merck — What You Need To Know
November 16, 2021
Warren Buffet's Berkshire Hathaway added more than 13 million shares.
Via
Investor's Business Daily
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care
November 12, 2021
Johnson & Johnson will split its consumer health unit into a publicly traded company.
Via
Investor's Business Daily
Veteran's Day
November 11, 2021
Stock markets took a tumble today across the board, but not as far down as at the opening.
Via
Talk Markets
Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M
November 11, 2021
Organon & Co (NYSE: OGN) has reported Q3 sales of $1.6 billion, down 1% Y/Y, slightly higher than the consensus of $1.58 billion. Women's Health declined...
Via
Benzinga
Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell
November 11, 2021
Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.